This opinion article by The University of Texas System Chancellor James B. Milliken mentions UT Health San Antonio and the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases. Read More (subscription required)
Share This Story
Sudha Seshadri, MD, founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article. Read More (subscription required)
Share This Story
Sudha Seshadri, MD, director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Kevin Bieniek, PhD, co-director of the Biggs Institute Brain Bank, were interviewed for this news story. Watch Now
Share This Story
Sudha Seshadri, MD, professor and founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article. Read More
Share This Story
Sudha Seshadri, MD, professor and founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article. Read More
Share This Story
Sudha Seshadri, MD, professor and founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was interviewed for this article. Read More
Share This Story
Sudha Seshadri, MD, professor and founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was interviewed for this article. Read More
Share This Story
Hispanics face nearly double the risk of developing Alzheimer’s disease compared to non-Hispanic whites, according to the National Institutes of Health National Institute on Aging.
Share This Story
Five years after the height of the SARS-CoV-2 (COVID-19) pandemic, scientists are beginning to unveil the infection’s potential long-term effects on the brain. We now know that following an acute COVID-19 infection, between 10% and 35% of people suffer from lingering effects called long COVID. For some people, these effects can be mild and short-lived, […]
Share This Story
Liang Ma, PhD, assistant professor at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and the Department of Pharmacology, and Agustin Ruiz, MD, professor and director of the Biggs Institute’s Biological Core laboratory, were both quoted in this article. Read More
Share This Story